Barbara Oldrini

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1.

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1.

Journal: eLife
Published: November 12, 2020

A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.

A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.

Journal: Nature communications
Published: October 16, 2019

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas.

Journal: Nature communications
Published: August 24, 2019

Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.

Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.

Journal: Nature communications
Published: July 22, 2017

EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.

EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.

Journal: Nature communications
Published: March 27, 2017

Take It Down a NOTCH in Forebrain Tumors.

Take It Down a NOTCH in Forebrain Tumors.

Journal: Cancer cell
Published: December 19, 2015

A kinase-independent function of AKT promotes cancer cell survival.

A kinase-independent function of AKT promotes cancer cell survival.

Journal: eLife
Published: June 22, 2014

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Journal: Science (New York, N.Y.)
Published: April 06, 2013

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Journal: Cancer discovery
Published: May 17, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026